Sellar surprises: a single-centre experience of unusual sellar masses.

abscess aneurysm astrocytoma granular cell tumor malignant peripheral nerve sheath tumor sellar suprasellar region

Journal

Endocrine connections
ISSN: 2049-3614
Titre abrégé: Endocr Connect
Pays: England
ID NLM: 101598413

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 28 12 2019
accepted: 07 01 2020
pubmed: 8 1 2020
medline: 8 1 2020
entrez: 8 1 2020
Statut: ppublish

Résumé

Most common incidentally detected sellar-suprasellar region (SSR) masses are pituitary adenomas, followed by craniopharyngioma, rathke's cleft cyst, hypophysitis, and meningioma. Besides these, certain unusual SSR lesions can sometimes present as diagnostic challenges, where diagnosis is often made post-operatively on histopathology, the pre-operative suspicion of which might have influenced the management strategies. Series describing such masses are few. To present clinical, biochemical, and radiological characteristics and management outcomes of rare SSR lesions other than pituitary adenomas, craniopharyngioma, rathke's cleft cyst, hypophysitis, and meningioma. Retrospective case record analysis of patients with uncommon SSR masses (from January 2006 to December 2016). Our series consisted of ten patients, five with neoplastic and five with non-neoplastic lesions. Neoplastic masses included granular cell tumor (n = 2), astrocytoma (n = 1), malignant peripheral nerve sheath tumor (MPNST, n = 1), and metastasis from occult papillary carcinoma of thyroid (n = 1), while non-neoplastic masses were aspergillus abscess (n = 1), sterile abscess (n = 1), and tubercular abscess (n = 1), aneurysm of left internal carotid artery (n = 1), and ruptured dermoid cyst (n = 1). All patients (except one) presented with headache and/or visual disturbance. Only one patient had acromegaly while most others had hypopituitarism. We describe detailed MRI characteristics of each of the lesion. Seven patients underwent trans-sphenoidal surgery. Post-operatively, five patients had permanent diabetes insipidus, while two patients died in early post-operative period. Our series expand the differential diagnostic considerations of SSR lesions. Most of the rare SSR masses present with symptoms of mass effects and hypopituitarism. Except for some non-neoplastic lesions like sellar abscesses, aneurysms, and dermoid cysts which can have some specific imaging characteristics that can provide clue to pre-operative diagnosis, most of the other neoplastic masses have overlapping radiological features, and pre-operative suspicion remains difficult.

Sections du résumé

BACKGROUND BACKGROUND
Most common incidentally detected sellar-suprasellar region (SSR) masses are pituitary adenomas, followed by craniopharyngioma, rathke's cleft cyst, hypophysitis, and meningioma. Besides these, certain unusual SSR lesions can sometimes present as diagnostic challenges, where diagnosis is often made post-operatively on histopathology, the pre-operative suspicion of which might have influenced the management strategies. Series describing such masses are few.
OBJECTIVE OBJECTIVE
To present clinical, biochemical, and radiological characteristics and management outcomes of rare SSR lesions other than pituitary adenomas, craniopharyngioma, rathke's cleft cyst, hypophysitis, and meningioma.
DESIGN, SETTING, PATIENTS METHODS
Retrospective case record analysis of patients with uncommon SSR masses (from January 2006 to December 2016).
RESULTS RESULTS
Our series consisted of ten patients, five with neoplastic and five with non-neoplastic lesions. Neoplastic masses included granular cell tumor (n = 2), astrocytoma (n = 1), malignant peripheral nerve sheath tumor (MPNST, n = 1), and metastasis from occult papillary carcinoma of thyroid (n = 1), while non-neoplastic masses were aspergillus abscess (n = 1), sterile abscess (n = 1), and tubercular abscess (n = 1), aneurysm of left internal carotid artery (n = 1), and ruptured dermoid cyst (n = 1). All patients (except one) presented with headache and/or visual disturbance. Only one patient had acromegaly while most others had hypopituitarism. We describe detailed MRI characteristics of each of the lesion. Seven patients underwent trans-sphenoidal surgery. Post-operatively, five patients had permanent diabetes insipidus, while two patients died in early post-operative period.
CONCLUSION CONCLUSIONS
Our series expand the differential diagnostic considerations of SSR lesions. Most of the rare SSR masses present with symptoms of mass effects and hypopituitarism. Except for some non-neoplastic lesions like sellar abscesses, aneurysms, and dermoid cysts which can have some specific imaging characteristics that can provide clue to pre-operative diagnosis, most of the other neoplastic masses have overlapping radiological features, and pre-operative suspicion remains difficult.

Identifiants

pubmed: 31910151
doi: 10.1530/EC-19-0497
pii: EC-19-0497.R1
pmc: PMC6993267
doi:
pii:

Types de publication

Journal Article

Langues

eng

Pagination

111-121

Références

Acta Neurochir (Wien). 2007 Feb;149(2):201-5; discussion 205-6
pubmed: 17195046
Neuroradiol J. 2019 Apr;32(2):92-97
pubmed: 30604653
Top Magn Reson Imaging. 2005 Jul;16(4):289-99
pubmed: 16785844
J Neurosurg. 2012 Jan;116(1):164-78
pubmed: 22054212
Pol J Radiol. 2018 Oct 19;83:e465-e470
pubmed: 30655926
J Neuropathol Exp Neurol. 2019 May 20;:null
pubmed: 31233145
Acta Radiol. 2017 Oct;58(10):1222-1230
pubmed: 28068826
J Clin Neurosci. 2014 Jan;21(1):184-5
pubmed: 23830587
PLoS One. 2016 Apr 20;11(4):e0152475
pubmed: 27097323
Endocr Connect. 2016 Jan;5(1):20-7
pubmed: 26682970
J Clin Neurosci. 2015 Apr;22(4):653-8
pubmed: 25560386
AJNR Am J Neuroradiol. 2011 Dec;32(11):2067-72
pubmed: 21960498
Neurosurgery. 2009 Dec;65(6):E1202; discussion E1202
pubmed: 19934939
Eur J Endocrinol. 2007 Feb;156(2):203-16
pubmed: 17287410
J Clin Endocrinol Metab. 2004 Feb;89(2):574-80
pubmed: 14764764
Rev Endocr Metab Disord. 2019 Jun;20(2):219-238
pubmed: 30864049
J Clin Neurosci. 2003 Jul;10(4):460-4
pubmed: 12852886
Pituitary. 2017 Apr;20(2):189-194
pubmed: 27696121
Endocr Connect. 2018 Aug 23;:null
pubmed: 30139817
Neurosurgery. 2008 Oct;63(4 Suppl 2):244-56; discussion 256
pubmed: 18981830
Endocrine. 2013 Jun;43(3):485-93
pubmed: 23008095
Acta Neurochir (Wien). 2006 Apr;148(4):457-62
pubmed: 16437187
Cancer. 1955 May-Jun;8(3):616-22
pubmed: 14379151
Eur Neurol. 2015;73(3-4):135-43
pubmed: 25531372
Endocrinol Metab Clin North Am. 1999 Mar;28(1):81-117, vi
pubmed: 10207686
Acta Neuropathol. 2017 Oct;134(4):521-535
pubmed: 28821944
J Neurosurg. 2003 Jun;98(6):1170-4
pubmed: 12816259
Clin Neurol Neurosurg. 2016 Oct;149:154-65
pubmed: 27540757
Radiother Oncol. 2019 Aug;137:61-70
pubmed: 31078939

Auteurs

Kunal Thakkar (K)

Department of Endocrinology, Seth G S Medical College & KEM Hospital, Mumbai, India.

Swati Ramteke-Jadhav (S)

Department of Endocrinology, Seth G S Medical College & KEM Hospital, Mumbai, India.

Rajeev Kasaliwal (R)

Department of Endocrinology, Mahatma Gandhi Medical College & Hospital, Jaipur, India.

Saba Samad Memon (SS)

Department of Endocrinology, Seth G S Medical College & KEM Hospital, Mumbai, India.

Virendra Patil (V)

Department of Endocrinology, Seth G S Medical College & KEM Hospital, Mumbai, India.

Puja Thadani (P)

Department of Endocrinology, Seth G S Medical College & KEM Hospital, Mumbai, India.

Nilesh Lomte (N)

Department of Endocrinology, Seth G S Medical College & KEM Hospital, Mumbai, India.

Shilpa Sankhe (S)

Department of Radiology, Seth G S Medical College & KEM Hospital, Mumbai, India.

Atul Goel (A)

Department of Neurosurgery, Seth G S Medical College & KEM Hospital, Mumbai, India.

Sridhar Epari (S)

Department of Pathology, Tata Memorial Centre, Mumbai, India.

Naina Goel (N)

Department of Neuropathology, Seth G S Medical College & KEM Hospital, Mumbai, India.

Anurag Lila (A)

Department of Endocrinology, Seth G S Medical College & KEM Hospital, Mumbai, India.

Nalini S Shah (NS)

Department of Endocrinology, Seth G S Medical College & KEM Hospital, Mumbai, India.

Tushar Bandgar (T)

Department of Endocrinology, Seth G S Medical College & KEM Hospital, Mumbai, India.

Classifications MeSH